Stock Movers: T-Mobile, MGM, and Incyte Discussed

T-Mobile's Competitive Landscape

• 📉 T-Mobile (TMUS) shares experienced an initial dip due to news of a new Trump-branded mobile service potentially creating competition.
• 💡 Despite this, analysts suggest T-Mobile is insulated due to its 5G leadership, which is projected to increase market share by 4.5% annually over the next three years.

MGM's Joint Venture Success

• 📈 MGM (MGM) shares rose over 4% following positive guidance updates from its sports betting joint venture, BetMGM.
• 📊 BetMGM, a venture with Entain, raised its net revenue and EBITDA guidance for fiscal year 2025 after a strong second quarter, benefiting brands like Ladbrokes and Party Poker.

Incyte's Clinical Trial Data Impresses

• 🚀 Incyte (INCY) shares also gained over 4% due to promising clinical trial data for an experimental therapy treating a blood disorder.
• ✅ The trial data showed no dose-limiting toxicities, with 98% of patients remaining on treatment, leading to an upgrade from Stifel analysts who cited a best-case scenario.